Skip to main content

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, María de los Ángeles Rodríguez Sánchez, Uría Oficialdegui, Maria Luz, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Elisabet Megías Roda, Raquel Hladun Alvaro, Ariadna Boloix Amenós, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Estudio fase IV, aleatorizado, abierto, controlado para evaluar la terminación temprana del tratamiento con antibioticos en pacientes oncohematológicos con neutropenia febril (e-STOP

IP: Pere Soler Palacín
Collaborators: Luís Gros Subias, Juliana Esperalba Esquerra, Natalia Ana Mendoza Palomar, Núria Worner Tomasa, Berta Sofia Fernandez Ledesma, Susana Melendo Perez
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI19/01522
Duration: 01/01/2020 - 30/06/2024

ESTRATEGIAS PARA MODULAR BRG1 COMO NUEVA TERAPIA PARA EL NEUROBLASTOMA

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Constantino Sábado Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI17/00564
Duration: 01/01/2018 - 31/12/2020

Nanoterapia basada en microRNAs: nuevo tratamiento para tumores pediátricos del sistema nervioso

IP: Miguel Segura Ginard
Collaborators: Luís Gros Subias, Aroa Soriano Fernández, Josep Sánchez de Toledo Codina, Constantino Sábado Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 116765
Reference: PI14/00561
Duration: 01/01/2015 - 31/12/2017

Related news

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.

Related professionals

Paula  Resta

Paula Resta

Predoctoral researcher
Read more
Valeria Rizzuto

Valeria Rizzuto

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Emanuela Greco

Emanuela Greco

Predoctoral researcher
Read more
Jose Cabral Jamba

Jose Cabral Jamba

Administrative
IT / Information Systems
Digital Transformation and Quality Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.